Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling

• Main Authors: Stein Schalkwijk, Rob Ter Heine, Angela Colbers, Edmund Capparelli, Brookie M. Best, Tim R. Cressey, Rick Greupink, Frans G.M. Russel, José Moltó, Mark Mirochnick, Mats O. Karlsson, David M. Burger
• Format: Journal
• Published: 2019
• Subjects: Medicine; Pharmacology, Toxicology and Pharmaceutics
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072058593&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/66721
• Institution: Chiang Mai University

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: [e-mail]. BACKGROUND: Darunavir 800 mg once (q24h) or 600 mg twice (q12h) daily combined with low-dose r...